Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Today's Top SOA Links


Molecular IVD Tests See Faster Revenue Growth Than Standard IVD: Report

NEW YORK, NY -- (Marketwire) -- 02/01/13 -- Tests aimed a molecular target for use in clinical decision-making will produce much faster revenue growth than traditional IVD tests, according to Kalorama Information. Kalorama Information said tests are a 5.2 billion dollar market and will grow 8% each year to 7.6 billion by 2017. That's four times as fast as revenue growth in standard chemistry tests and twice as fast as immunoassay markets, according to the company's IVD market research database. The finding was made in its recent report, "The World Market for Molecular Diagnostics, 5th Edition."

The continued discovery of genetic markers with proven clinical utility and the increasing adoption of genetic based diagnostic tests are driving usage. The most attractive growth areas are molecular tests for histological analyses, women's health, infectious diseases, organ transplant testing and oncology. New tests are being launched all the time. Many molecular tests are CE Marked and FDA-cleared and many more are in development.

"These are exciting times for molecular diagnostics," said Shara Rosen, Kalorama Information's lead analyst and author of the report. "It represents one of the fastest growing segments of the diagnostics market. It has emerged fully from research into clinical practice."

Instrumentation now automates many of the sample preparation and assay steps that were formerly labor intensive. There are many new tests, technologies and companies. Competition is becoming very intense. The competition, according to Kalorama is not only between companies and products but also between technologies. There are RNA, DNA and protein patterns, sequencing, tissue arrays, circulating cells and cell-free nucleic acids. The ensemble of these elements create a market for a wide variety of options -- multiplexed, rapid, user friendly test platforms such as microarrays, liquid bead arrays and other user-friendly technologies. But the report is careful to note that not all new technologies can be a success -- with so many technologies and platforms to choose from, some of the valuable but less aggressively promoted products may fall by the wayside. Also, molecular tests, especially for inherited diseases and some FISH analyses are extremely complex. The tests provide raw data, the interpretation of which sometimes baffle even the most experienced molecular biologists.

"Optimism for the future benefits to modern medicine is tempered by the fact that the big payoff is still a way off," said Rosen. "Finding the genes that can raise the risk of an illness doesn't mean you can prevent the disease. And developing a treatment for it can take years."

One of the major challenges facing molecular testing is getting stakeholders including payers, physicians, researchers and regulators to work together to close the gap between research and clinical applicability. Physician education is another area that could advance the use of molecular assays. Still Rosen feels that the ensemble of these elements create a dynamic, energetic and fast-moving environment for new tests and companies. This chapter provides an overview of the market forces and their impact on molecular tests.

The Report, "The World Market for Molecular Diagnostics, 5th Edition" presents further growth rates for sub markets within molecular testing, regional breakouts of revenue figures, important strategic conclusions for companies in the market, profiles of companies in the market. The report can be found at http://www.kaloramainformation.com/Molecular-Diagnostics-Edition-7295219/

About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog.

Add to Digg Bookmark with del.icio.us Add to Newsvine

About Marketwired .
Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Web 2.0 Latest News
Are you still pondering whether to integrate cloud computing services into the structure of your IT network? You are not the only one. Most IT professionals are very concerned about data security, so they aren’t that willing to switch to cloud computing solutions that easily. It’s a fa...
Having automated workflows sounds like a sexy thing. And it is. It feels pretty awesome to be able to initiate a process with a button and forget about it while the work gets done. But that doesn’t mean you have to automate every process in your office. I mean, I think people can take...
I'm often guilty of sticking my head in the sand, ignoring very small details that could turn into big problems later on. Like when Netflix told me my credit card was about to expire, but it seemed like such a boring task, so I ignored them...till the day Netflix stopped working. I gru...
It seems like every day we see reminders of the importance of thorough security testing from all areas of the software world. Security has become an especially critical consideration for APIs in recent years. Organizations rely on APIs to share and receive information - either from a t...
Clouds are typically classified into four different topologies: private, public, community and hybrid clouds. Let’s focus on hybrid clouds: what are the use cases that require this topology, what are the challenges, and who stands to benefit from the hybrid cloud trend? First off, a d...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE